Zukunft mammographiebasierter Bildgebung

Schulz‐Wendtland, Rüdiger; Wittenberg, Thomas; Michel, Thilo; Hartmann, Arndt; Beckmann, Matthias W.; Rauh, Claudia; Jud, Sebastian M.; Brehm, B.; Meier-Meitinger, M.; Anton, G.; Uder, Michael; Fasching, Peter A.

doi:10.1007/s00117-013-2578-2

Cited by 10 publications

(8 citation statements)

References 66 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…An der Optimierung der Sensitivität und Spezifität sowie der Qualität der Mammabildgebung wird kontinuierlich geforscht, unter anderem verspricht die Fusion mehrerer bildgebender Methoden eine Weiterentwicklung in der Mammadiagnostik [64,65]. Durch die Fusion von unterschiedlichen bildgebenden Methoden in einem Arbeitsschritt könnten verschiedene Fragestellungen beantwortet werden.…”

Section: Fusion Mit Anderen Diagnostischen Methodenunclassified

“…There is ongoing research underway to optimize the sensitivity, specificity, and quality of breast imaging; among other things, the fusion of several imaging methods promises further development in breast diagnostics [64,65]. Combining different imaging methods into one single work step, may allow to answer several different questions simultaneously.…”

Section: Fusion With Different Diagnostic Methodsmentioning

confidence: 99%

“…This can result in better image resolution or spatial representation. Assertions about the metabolic activity of the examined tissue could also be made, as has already been done in clinical diagnostics in terms of combining CT and positron emission tomography [64,66]. Another advantage of combining different imaging lies in the more precise allocation of the region of interest (ROI) in one imaging modality relative to another modality.…”

Section: Fusion With Different Diagnostic Methodsmentioning

confidence: 99%

“…In der Routinediagnostik hat sich die Fusionsbildgebung bislang nicht etabliert, Gründe dafür sind die aktuell noch experimentellen Ansätze und die damit verbundenen Kosten. Aktuell ist keine standardisierte Befundung der Bilder möglich [64,69,70]. Die potenziellen Einsatzmöglichkeiten dieser Techniken, sowohl im Screening als auch in der Routine-Diagnostik, sind vielfältig und durch weitere Forschungen könnte die Fusionsbildgebung Einzug in die Routine der Mammadiagnostik finden [71,72,73].…”

Section: Conclusiounclassified

See 3 more Smart Citations

Best Practice Guideline – Empfehlungen der DEGUM zur Durchführung und Beurteilung der Mammasonografie

Vogel-Minea¹,

Bader

Blohmer

et al. 2023

Ultraschall Med

View full text Add to dashboard Cite

ZusammenfassungDie Mammasonografie hat sich seit vielen Jahren neben der Mammografie als wichtige Methode zur Abklärung von Brustbefunden etabliert.Der Arbeitskreis Mammasonografie der DEGUM beabsichtigt mit der „Best Practice Guideline“ den senologisch tätigen Kolleginnen und Kollegen neben dem in Teil I publizierten aktuellen Dignitätskriterien- und Befundungskatalog in dem vorliegenden Teil II die additiven und fakultativen Anwendungsmodalitäten zur Abklärung von Brustbefunden zu beschreiben und dazu DEGUM-Empfehlungen zu äußern, um die Differenzialdiagnose von unklaren Läsionen zu erleichtern.Die vorliegende „Best Practice Guideline“ hat sich zum Ziel gesetzt, den Anforderungen zur Qualitätssicherung und der Gewährleistung einer qualitätskontrollierten Durchführung der Mammasonografie nachzukommen. Die wichtigsten Aspekte der Qualitätssicherung werden in diesem Teil II der Best Practice Guideline erläutert.

show abstract

Section: Fusion Mit Anderen Diagnostischen Methodenunclassified

Section: Fusion With Different Diagnostic Methodsmentioning

confidence: 99%

Section: Fusion With Different Diagnostic Methodsmentioning

confidence: 99%

Section: Conclusiounclassified

See 2 more Smart Citations

Best Practice Guideline – Empfehlungen der DEGUM zur Durchführung und Beurteilung der Mammasonografie

Vogel-Minea¹,

Bader

Blohmer

et al. 2023

Ultraschall Med

View full text Add to dashboard Cite

show abstract

“…Recently, it has also been discussed whether screening programs can effectively reduce mortality because aggressive forms of cancer are missed 83 , 84 , 85 . So the question arises, whether the risk for aggressive forms of breast cancer is high enough in the screened population 86 .…”

Section: Screening For Different Risk Populationsmentioning

confidence: 99%

Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data

Wunderle

Olmes

Nabieva

et al. 2018

Geburtshilfe Frauenheilkd

View full text Add to dashboard Cite

Over the last two decades genetic testing for mutations in BRCA1 and BRCA2 has become standard of care for women and men who are at familial risk for breast or ovarian cancer. Currently, genetic testing more often also includes so-called panel genes, which are assumed to be moderate-risk genes for breast cancer. Recently, new large-scale studies provided more information about the risk estimation of those genes. The utilization of information on panel genes with regard to their association with the individual breast cancer risk might become part of future clinical practice. Furthermore, large efforts have been made to understand the influence of common genetic variants with a low impact on breast cancer risk. For this purpose, almost 450 000 individuals have been genotyped for almost 500 000 genetic variants in the OncoArray project. Based on first results it can be assumed that – together with previously identified common variants – more than 170 breast cancer risk single nucleotide polymorphisms can explain up to 18% of familial breast cancer risk. The knowledge about genetic and non-genetic risk factors and its implementation in clinical practice could especially be of use for individualized prevention. This includes an individualized risk prediction as well as the individualized selection of screening methods regarding imaging and possible lifestyle interventions. The aim of this review is to summarize the most recent developments in this area and to provide an overview on breast cancer risk genes, risk prediction models and their utilization for the individual patient.

show abstract

Semi‐automated delineation of breast cancer tumors and subsequent materialization using three‐dimensional printing (rapid prototyping)

Schulz‐Wendtland

Harz

Meier-Meitinger

et al. 2016

Journal of Surgical Oncology

View full text Add to dashboard Cite

3D printing (rapid prototyping) appears to be feasible. Scenarios for the clinical use of the technology might include presenting the model to the surgeon to provide a better understanding of the tumor's spatial characteristics in the breast, in order to improve decision-making in relation to neoadjuvant chemotherapy or surgical approaches. J. Surg. Oncol. 2017;115:238-242. © 2016 Wiley Periodicals, Inc.

show abstract

Zukunft mammographiebasierter Bildgebung

Cited by 10 publications

References 66 publications

Best Practice Guideline – Empfehlungen der DEGUM zur Durchführung und Beurteilung der Mammasonografie

Best Practice Guideline – Empfehlungen der DEGUM zur Durchführung und Beurteilung der Mammasonografie

Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data

Semi‐automated delineation of breast cancer tumors and subsequent materialization using three‐dimensional printing (rapid prototyping)

Contact Info

Product

Resources

About